I 3 Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for I 3 PHARMS, and what generic and branded alternatives to I 3 PHARMS drugs are available?
I 3 PHARMS has three approved drugs.
Drugs and US Patents for I 3 Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
I 3 Pharms | MARAVIROC | maraviroc | TABLET;ORAL | 217114-001 | Aug 17, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
I 3 Pharms | MARAVIROC | maraviroc | TABLET;ORAL | 217114-002 | Aug 17, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
I 3 Pharms | POSACONAZOLE | posaconazole | TABLET, DELAYED RELEASE;ORAL | 216488-001 | Aug 28, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
I 3 Pharms | GUANFACINE HYDROCHLORIDE | guanfacine hydrochloride | TABLET;ORAL | 216828-002 | Oct 5, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
I 3 Pharms | GUANFACINE HYDROCHLORIDE | guanfacine hydrochloride | TABLET;ORAL | 216828-001 | Oct 5, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.